Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2014

View Archived Issues

Novel compounds target the FtsZ protein in M. tuberculosis

Genome-wide screening for rare genetic variants associated with RLS

In vivo results reveal potent antitumor activity for the novel pan-Notch inhibitor BMS-986115

LC-MS/MS assay can detect vitamin B12 deficiency

Immune Targeting Systems partners its H1N1 influenza challenge virus

Alcobra enrolls first patient in phase IIb study of metadoxine in fragile X syndrome

Mitsubishi Tanabe Pharma and AstraZeneca form diabetic nephropathy collaboration

Garvan and Roche Sequencing to collaborate on targeted epigenomic analysis using DNA sequencing

Sinocelltech to conduct phase I study of anti-EGFR antibody in patients with colorectal cancer

Nogo-A, a valid target for ALS therapy

Emergent BioSolutions and MorphoSys to co-develop bispecific protein for prostate cancer

Eisai files for U.S. and E.U. approval of perampanel for primary generalized tonic-clonic seizures

Novel pyridones inhibit T790M double mutant EGFR

Novartis provides candidate compounds to Global Alliance for TB Drug Development

Isis Pharmaceuticals to begin phase III trial in familial chylomicronemia syndrome

Bayer Schering Pharma patents new Mnk1 inhibitors

Chinese researchers divulge novel DHODH inhibitors

Gruenenthal patents new PDE4B inhibitors

New mGlu4 receptor PAMs described by Merck KGaA

CSL Behring's Hizentra obtains orphan drug status for CIDP

NovaBay reports phase II data for NVC-422 in viral conjunctivitis

NCI launches nationwide trial to assess targeted drugs in early-stage lung cancer

U.S. rights For Treximet acquired by Pernix Therapeutics

Stemedica's stem cell therapy reduces Abeta plaques in Alzheimer's disease model

Fluticasone furoate inhalation powder approved in the US for asthma

Marketing approval granted for KRONUS ZnT8Ab ELISA Assay for diagnosis of type 1 diabetes

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026